高级检索
当前位置: 首页 > 详情页

Renin-angiotensin system regulates pulmonary arterial smooth muscle cell migration in chronic thromboembolic pulmonary hypertension

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing,China [2]Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Beijing Chao-Yang Hospital, CapitalMedical University, Beijing, China [3]Beijing Institute of Respiratory Medicine, Beijing, China [4]Department of RespiratoryDisease, Capital Medical University, Beijing, China [5]Department of Cardiac Surgery, Beijing Chao-Yang Hospital, CapitalMedical University, Beijing, China [6]Department of Pathology, Haidian Maternal & Child Health Hospital, Beijing, China [7]China-Japan Friendship Hospital, Beijing, China [8]National Clinical Research Center for Respiratory Diseases,Beijing, China
出处:
ISSN:

关键词: chronic thromboembolic pulmonary hypertension migration pulmonary arterial smooth muscle cell renin-angiotensin system

摘要:
Pulmonary arterial smooth muscle cell (PASMC) migration plays a key role in vascular remodeling, which occurs during development of chronic thromboembolic pulmonary hypertension (CTEPH). Activation of the renin-angiotensin system (RAS) contributes to vascular remodeling observed in many diseases, including idiopathic pulmonary arterial hypertension. However, the role of RAS imbalance in CTEPH has not been characterized. Here, we hypothesize that RAS imbalance regulates vascular remodeling by promoting PASMC migration in CTEPH. Serum renin and angiotensin II levels in patients with CTEPH were quantified by ELISA. The pulmonary endarterectomy tissues were stained and analyzed by immunohistochemistry. PASMCs were isolated and verified by immunofluorescence staining. PASMC migration was determined by Transwell assay. Phosphorylation and protein level were detected by Western blotting. Serum levels of renin and angiotensin II were increased in patients with CTEPH {renin [median (25th percentile, 75th percentile) in pg/ml], 1,199.94 [690.85, 1,656.90] vs. 595.43 [351.48, 936.43], P < 0.001; angiotensin II [in pg/ml], 63.97 [45.97, 345.24] vs. 56.85 [11.20, 90.37], P < 0.05}. The migration of PASMCs isolated from patients with CTEPH was enhanced compared with control. Angiotensin II promoted the migration of PASMCs via activation of angiotensin II receptor 1 and phosphorylation of ERK1/2, whereas angiotensin-(1-7) counteracted this effect through activation of the Mas receptor and ERK1/2. These results demonstrate that the renin-angiotensin system regulates migration of PASMCs from patients with CTEPH via the ERK1/2 pathway. Our findings suggest that angiotensin-(1-7) or reagents targeting the renin-angiotensin system will be beneficial in the development of novel therapies for CTEPH.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 生理学 2 区 呼吸系统
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 生理学 3 区 呼吸系统
JCR分区:
出版当年[2016]版:
Q1 PHYSIOLOGY Q1 RESPIRATORY SYSTEM
最新[2023]版:
Q1 PHYSIOLOGY Q1 RESPIRATORY SYSTEM

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2016版] 出版当年五年平均[2012-2016] 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者单位: [1]Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing,China [2]Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Beijing Chao-Yang Hospital, CapitalMedical University, Beijing, China [3]Beijing Institute of Respiratory Medicine, Beijing, China [4]Department of RespiratoryDisease, Capital Medical University, Beijing, China
共同第一作者:
通讯作者:
通讯机构: [2]Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Beijing Chao-Yang Hospital, CapitalMedical University, Beijing, China [4]Department of RespiratoryDisease, Capital Medical University, Beijing, China [7]China-Japan Friendship Hospital, Beijing, China [8]National Clinical Research Center for Respiratory Diseases,Beijing, China [*1]Dept. of Respiratory Disease, Capital Medical Univ., Beijing 100069, P. R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)